| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.985 | 0 | 0.985 | Retinoic acid receptor agonist | 0.938 0.001 DBMET02045 0.971 0 DBMET02046 | ||
| 0.935 | 0.001 | 0.935 | Retinoic acid receptor gamma antagonist | 0.8 0.001 DBMET02045 0.915 0.001 DBMET02046 | ||
| 0.933 | 0 | 0.933 | Retinoic acid beta receptor agonist | 0.798 0.001 DBMET02045 0.901 0.001 DBMET02046 | ||
| 0.937 | 0.005 | 0.937 | Apoptosis agonist | 0.905 0.005 DBMET02045 0.894 0.006 DBMET02046 | ||
| 0.911 | 0 | 0.911 | Retinoic acid gamma receptor agonist | 0.69 0.001 DBMET02045 0.861 0 DBMET02046 | ||
| 0.903 | 0.001 | 0.909 | Retinoic acid alpha receptor antagonist | 0.746 0.001 DBMET02045 0.909 0.001 DBMET02046 | DBMET02046 | |
| 0.894 | 0.001 | 0.894 | Retinoic acid beta receptor antagonist | 0.654 0.001 DBMET02045 0.894 0.001 DBMET02046 | ||
| 0.891 | 0.001 | 0.891 | Retinoic acid receptor antagonist | 0.797 0.001 DBMET02045 0.888 0.001 DBMET02046 | ||
| 0.874 | 0.001 | 0.891 | ABCA1 expression enhancer | 0.797 0.002 DBMET02045 0.891 0.001 DBMET02046 | DBMET02046 | |
| 0.829 | 0.012 | 0.829 | Antiinflammatory | 0.816 0.013 DBMET02045 0.801 0.015 DBMET02046 | ||
| 0.816 | 0.004 | 0.816 | Antioxidant | 0.762 0.005 DBMET02045 0.739 0.005 DBMET02046 | ||
| 0.799 | 0.001 | 0.799 | Retinoic acid alpha receptor agonist | 0.666 0.001 DBMET02045 0.789 0.001 DBMET02046 | ||
| 0.798 | 0 | 0.835 | Retinoid X gamma receptor antagonist | 0.475 0 DBMET02045 0.835 0 DBMET02046 | DBMET02046 | |
| 0.736 | 0.017 | 0.823 | Transcription factor NF kappa B inhibitor | 0.788 0.014 DBMET02045 0.823 0.011 DBMET02046 | DBMET02046 | |
| 0.713 | 0 | 0.779 | Retinoid X gamma receptor agonist | 0.511 0.001 DBMET02045 0.779 0 DBMET02046 | DBMET02046 | |
| 0.705 | 0 | 0.785 | Retinoid X beta receptor agonist | 0.532 0.001 DBMET02045 0.785 0 DBMET02046 | DBMET02046 | |
| 0.621 | 0.009 | 0.621 | Caspase 3 stimulant | 0.596 0.01 DBMET02045 0.501 0.02 DBMET02046 | ||
| 0.604 | 0.002 | 0.806 | Ornithine decarboxylase inhibitor | 0.569 0.002 DBMET02045 0.806 0.001 DBMET02046 | DBMET02046 | |
| 0.602 | 0.001 | 0.77 | Keratolytic | 0.634 0.001 DBMET02045 0.77 0.001 DBMET02046 | DBMET02046 | |
| 0.605 | 0.009 | 0.617 | Nitric oxide antagonist | 0.617 0.009 DBMET02045 0.533 0.014 DBMET02046 | DBMET02045 | |
| 0.603 | 0.008 | 0.603 | Free radical scavenger | 0.519 0.014 DBMET02045 0.54 0.013 DBMET02046 | ||
| 0.615 | 0.022 | 0.699 | 15-Lipoxygenase inhibitor | 0.699 0.013 DBMET02045 0.64 0.019 DBMET02046 | DBMET02045 | |
| 0.569 | 0.001 | 0.569 | Transcription factor AP-1 inhibitor | 0.506 0.002 DBMET02045 0.532 0.001 DBMET02046 | ||
| 0.552 | 0.011 | 0.64 | Hypoglycemic | 0.524 0.013 DBMET02045 0.64 0.006 DBMET02046 | DBMET02046 | |
| 0.559 | 0.019 | 0.59 | Immunosuppressant | 0.59 0.014 DBMET02045 0.561 0.019 DBMET02046 | DBMET02045 | |
| 0.54 | 0.004 | 0.545 | Aldehyde dehydrogenase inhibitor | 0.543 0.004 DBMET02045 0.545 0.004 DBMET02046 | DBMET02046 | |
| 0.534 | 0.001 | 0.893 | Retinoid X alpha receptor agonist | 0.569 0.001 DBMET02045 0.893 0 DBMET02046 | DBMET02046 | |
| 0.495 | 0.005 | 0.495 | Lipid peroxidase inhibitor | 0.493 0.005 DBMET02045 0.408 0.009 DBMET02046 | ||
| 0.47 | 0.001 | 0.834 | Retinoid X receptor agonist | 0.508 0.001 DBMET02045 0.834 0 DBMET02046 | DBMET02046 | |
| 0.466 | 0.024 | 0.539 | Lipoxygenase inhibitor | 0.539 0.014 DBMET02045 0.516 0.017 DBMET02046 | DBMET02045 | |
| 0.458 | 0.016 | 0.526 | Hypolipemic | 0.449 0.018 DBMET02045 0.526 0.01 DBMET02046 | DBMET02046 | |
| 0.496 | 0.061 | 0.496 | Caspase 9 stimulant | 0.434 0.092 DBMET02045 0.496 0.061 DBMET02046 | ||
| 0.364 | 0.001 | 0.798 | Retinoid X beta receptor antagonist | 0.317 0.001 DBMET02045 0.798 0 DBMET02046 | DBMET02046 | |
| 0.362 | 0.002 | 0.362 | Adenylate cyclase stimulant | 0.347 0.002 DBMET02045 0.358 0.002 DBMET02046 | ||
| 0.406 | 0.048 | 0.472 | Immunostimulant | 0.472 0.033 DBMET02045 0.426 0.042 DBMET02046 | DBMET02045 | |
| 0.383 | 0.03 | 0.383 | Tumour necrosis factor alpha release inhibitor | 0.344 0.039 DBMET02045 0.268 0.067 DBMET02046 | ||
| 0.359 | 0.013 | 0.383 | Interferon gamma antagonist | 0.383 0.012 DBMET02045 0.355 0.014 DBMET02046 | DBMET02045 | |
| 0.352 | 0.008 | 0.547 | Phospholipase A2 inhibitor | 0.373 0.006 DBMET02045 0.547 0.003 DBMET02046 | DBMET02046 | |
| 0.345 | 0.001 | 0.721 | Retinoid X receptor antagonist | 0.298 0.001 DBMET02045 0.721 0 DBMET02046 | DBMET02046 | |
| 0.391 | 0.058 | 0.435 | Vasodilator, peripheral | 0.341 0.078 DBMET02045 0.435 0.045 DBMET02046 | DBMET02046 | |
| 0.405 | 0.075 | 0.466 | Antibacterial | 0.466 0.051 DBMET02045 0.458 0.054 DBMET02046 | DBMET02045 | |
| 0.328 | 0.008 | 0.328 | Antineoplastic antibiotic | 0.299 0.01 DBMET02045 0.275 0.011 DBMET02046 | ||
| 0.319 | 0.001 | 0.708 | Retinoid X alpha receptor antagonist | 0.274 0.001 DBMET02045 0.708 0 DBMET02046 | DBMET02046 | |
| 0.385 | 0.099 | 0.625 | Cyclophilin D inhibitor | 0.426 0.077 DBMET02045 0.625 0.023 DBMET02046 | DBMET02046 | |
| 0.319 | 0.057 | 0.342 | Hypoxia-inducible factor 1 alpha inhibitor | 0.267 0.086 DBMET02045 0.342 0.047 DBMET02046 | DBMET02046 | |
| 0.254 | 0.012 | 0.254 | Neurotrophic factor | 0.205 0.025 DBMET02045 0.184 0.036 DBMET02046 | ||
| 0.365 | 0.124 | 0.365 | Transcription factor inhibitor | 0.256 0.182 DBMET02045 0.263 0.178 DBMET02046 | ||
| 0.31 | 0.079 | 0.368 | Apoptosis antagonist | 0.368 0.048 DBMET02045 0.35 0.056 DBMET02046 | DBMET02045 | |
| 0.24 | 0.01 | 0.24 | Androgen antagonist | 0.177 0.016 DBMET02045 0.168 0.018 DBMET02046 | ||
| 0.28 | 0.051 | 0.371 | DNA synthesis inhibitor | 0.277 0.052 DBMET02045 0.371 0.026 DBMET02046 | DBMET02046 | |
| 0.261 | 0.033 | 0.269 | Neurotrophic factor enhancer | 0.237 0.046 DBMET02045 0.269 0.029 DBMET02046 | DBMET02046 | |
| 0.236 | 0.017 | 0.236 | Alpha 2b adrenoreceptor antagonist | 0.134 0.048 DBMET02045 0.119 0.059 DBMET02046 | ||
| 0.322 | 0.112 | 0.421 | Histamine release inhibitor | 0.302 0.122 DBMET02045 0.421 0.065 DBMET02046 | DBMET02046 | |
| 0.237 | 0.029 | 0.277 | Antipruritic | 0.163 0.081 DBMET02045 0.277 0.018 DBMET02046 | DBMET02046 | |
| 0.215 | 0.018 | 0.256 | Farnesoid X receptor antagonist | 0.184 0.027 DBMET02045 0.256 0.01 DBMET02046 | DBMET02046 | |
| 0.216 | 0.02 | 0.245 | Arachidonic acid antagonist | 0.22 0.017 DBMET02045 0.245 0.007 DBMET02046 | DBMET02046 | |
| 0.223 | 0.033 | 0.223 | Melanin inhibitor | 0.205 0.039 DBMET02045 0.209 0.037 DBMET02046 | ||
| 0.344 | 0.157 | 0.344 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.217 | 0.031 | 0.26 | Bone formation stimulant | 0.214 0.032 DBMET02045 0.26 0.023 DBMET02046 | DBMET02046 | |
| 0.194 | 0.021 | 0.194 | Microtubule formation inhibitor | 0.168 0.03 DBMET02045 0.189 0.022 DBMET02046 | ||
| 0.225 | 0.052 | 0.278 | Hepatoprotectant | 0.278 0.036 DBMET02045 0.273 0.038 DBMET02046 | DBMET02045 | |
| 0.182 | 0.015 | 0.182 | TRPA1 agonist | 0.122 0.056 DBMET02045 0.152 0.029 DBMET02046 | ||
| 0.201 | 0.041 | 0.256 | Protein kinase stimulant | 0.19 0.045 DBMET02045 0.256 0.025 DBMET02046 | DBMET02046 | |
| 0.276 | 0.117 | 0.276 | Calcium channel activator | 0.206 0.205 DBMET02046 | ||
| 0.267 | 0.117 | 0.267 | Vasodilator, coronary | 0.247 0.138 DBMET02045 0.21 0.173 DBMET02046 | ||
| 0.189 | 0.048 | 0.189 | ATPase inhibitor | 0.149 0.102 DBMET02045 0.171 0.069 DBMET02046 | ||
| 0.155 | 0.018 | 0.155 | Electron transport complex I inhibitor | 0.128 0.038 DBMET02045 0.122 0.045 DBMET02046 | ||
| 0.172 | 0.038 | 0.212 | DNA polymerase I inhibitor | 0.161 0.044 DBMET02045 0.212 0.024 DBMET02046 | DBMET02046 | |
| 0.187 | 0.06 | 0.265 | Succinate dehydrogenase inhibitor | 0.209 0.042 DBMET02045 0.265 0.018 DBMET02046 | DBMET02046 | |
| 0.154 | 0.033 | 0.154 | Ca2+-transporting ATPase inhibitor | 0.151 0.039 DBMET02045 0.151 0.041 DBMET02046 | ||
| 0.159 | 0.042 | 0.214 | Alkylator | 0.214 0.023 DBMET02045 0.201 0.026 DBMET02046 | DBMET02045 | |
| 0.188 | 0.072 | 0.194 | P-glycoprotein inhibitor | 0.194 0.068 DBMET02045 0.143 0.128 DBMET02046 | DBMET02045 | |
| 0.129 | 0.014 | 0.129 | ATPase (Vacuolar H+) inhibitor | 0.118 0.021 DBMET02045 0.125 0.017 DBMET02046 | ||
| 0.22 | 0.111 | 0.22 | Transcription factor STAT3 inhibitor | 0.211 0.12 DBMET02045 0.18 0.164 DBMET02046 | ||
| 0.223 | 0.115 | 0.261 | Gastrin inhibitor | 0.261 0.067 DBMET02046 | DBMET02046 | |
| 0.11 | 0.005 | 0.11 | Exportin-1 inhibitor | 0.083 0.021 DBMET02045 0.109 0.006 DBMET02046 | ||
| 0.146 | 0.043 | 0.146 | Vanilloid 1 agonist | 0.14 0.05 DBMET02045 0.142 0.047 DBMET02046 | ||
| 0.148 | 0.045 | 0.254 | Cholesterol synthesis inhibitor | 0.147 0.046 DBMET02045 0.254 0.017 DBMET02046 | DBMET02046 | |
| 0.114 | 0.012 | 0.14 | CDC25B inhibitor | 0.087 0.022 DBMET02045 0.14 0.008 DBMET02046 | DBMET02046 | |
| 0.116 | 0.018 | 0.118 | Thioredoxin reductase inhibitor | 0.118 0.018 DBMET02045 0.095 0.033 DBMET02046 | DBMET02045 | |
| 0.127 | 0.033 | 0.127 | Anabolic | 0.107 0.053 DBMET02045 0.121 0.039 DBMET02046 | ||
| 0.114 | 0.02 | 0.114 | Na+ K+ transporting ATPase inhibitor | 0.112 0.022 DBMET02045 0.111 0.022 DBMET02046 | ||
| 0.095 | 0.008 | 0.095 | Heme oxygenase stimulant | 0.08 0.015 DBMET02045 0.082 0.014 DBMET02046 | ||
| 0.094 | 0.007 | 0.094 | Glucose-6-phosphate translocase inhibitor | 0.069 0.017 DBMET02045 0.075 0.013 DBMET02046 | ||
| 0.163 | 0.077 | 0.163 | Sigma receptor agonist | |||
| 0.089 | 0.004 | 0.089 | Pregnane X receptor antagonist | 0.077 0.008 DBMET02045 0.077 0.008 DBMET02046 | ||
| 0.135 | 0.053 | 0.191 | Protein-tyrosine phosphatase 1B inhibitor | 0.177 0.036 DBMET02045 0.191 0.032 DBMET02046 | DBMET02046 | |
| 0.181 | 0.103 | 0.181 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.149 | 0.079 | 0.224 | Protein-tyrosine phosphatase inhibitor | 0.204 0.045 DBMET02045 0.224 0.038 DBMET02046 | DBMET02046 | |
| 0.104 | 0.034 | 0.104 | Inducible nitric-oxide synthase inhibitor | |||
| 0.077 | 0.007 | 0.132 | Liver X receptor alpha agonist | 0.058 0.014 DBMET02045 0.132 0.004 DBMET02046 | DBMET02046 | |
| 0.141 | 0.072 | 0.141 | Pregnane X receptor agonist | |||
| 0.076 | 0.008 | 0.085 | Factor III inhibitor | 0.085 0.006 DBMET02045 0.065 0.013 DBMET02046 | DBMET02045 | |
| 0.187 | 0.12 | 0.19 | RNA-directed DNA polymerase inhibitor | 0.19 0.115 DBMET02045 | DBMET02045 | |
| 0.081 | 0.014 | 0.081 | Histamine agonist | |||
| 0.07 | 0.004 | 0.09 | Kainate receptor agonist | 0.056 0.009 DBMET02045 0.09 0.003 DBMET02046 | DBMET02046 | |
| 0.192 | 0.126 | 0.192 | Superoxide dismutase inhibitor | 0.179 0.143 DBMET02045 0.191 0.128 DBMET02046 | ||
| 0.093 | 0.031 | 0.093 | Lipase inhibitor | |||
| 0.157 | 0.098 | 0.232 | Platelet adhesion inhibitor | 0.232 0.056 DBMET02046 | DBMET02046 | |
| 0.092 | 0.033 | 0.208 | Peroxisome proliferator-activated receptor gamma agonist | 0.107 0.024 DBMET02045 0.208 0.006 DBMET02046 | DBMET02046 | |
| 0.126 | 0.068 | 0.126 | Cathepsin H inhibitor | |||
| 0.07 | 0.012 | 0.07 | Adenylate cyclase 1 inhibitor | 0.042 0.039 DBMET02045 | ||
| 0.124 | 0.072 | 0.124 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.063 | 0.013 | 0.065 | Collagenase inhibitor | 0.058 0.018 DBMET02045 0.065 0.012 DBMET02046 | DBMET02046 | |
| 0.152 | 0.102 | 0.158 | Phospholipase C inhibitor | 0.155 0.097 DBMET02045 0.158 0.092 DBMET02046 | DBMET02046 | |
| 0.183 | 0.137 | 0.183 | 5 Hydroxytryptamine release stimulant | |||
| 0.091 | 0.049 | 0.091 | Transcription factor NF kappa B stimulant | 0.087 0.055 DBMET02045 0.089 0.052 DBMET02046 | ||
| 0.049 | 0.008 | 0.053 | HMG CoA reductase inhibitor | 0.046 0.009 DBMET02045 0.053 0.006 DBMET02046 | DBMET02046 | |
| 0.222 | 0.182 | 0.222 | GABA C receptor rho-3 antagonist | |||
| 0.042 | 0.005 | 0.042 | Vitamin D receptor antagonist | 0.032 0.006 DBMET02045 0.029 0.008 DBMET02046 | ||
| 0.048 | 0.011 | 0.072 | Liver X receptor beta agonist | 0.033 0.023 DBMET02045 0.072 0.007 DBMET02046 | DBMET02046 | |
| 0.104 | 0.067 | 0.146 | Ferrochelatase inhibitor | 0.146 0.039 DBMET02046 | DBMET02046 | |
| 0.091 | 0.055 | 0.091 | Alpha 2 adrenoreceptor antagonist | |||
| 0.071 | 0.039 | 0.071 | Histone deacetylase inhibitor | |||
| 0.08 | 0.049 | 0.08 | Estrogen receptor alpha antagonist | 0.071 0.065 DBMET02045 0.075 0.057 DBMET02046 | ||
| 0.098 | 0.068 | 0.099 | Estrogen receptor beta antagonist | 0.099 0.066 DBMET02045 0.094 0.075 DBMET02046 | DBMET02045 | |
| 0.107 | 0.077 | 0.113 | Photosensitizer | 0.113 0.067 DBMET02045 0.108 0.074 DBMET02046 | DBMET02045 | |
| 0.05 | 0.022 | 0.05 | Parathyroid hormone antagonist | 0.043 0.036 DBMET02045 | ||
| 0.041 | 0.014 | 0.041 | Tubulin agonist | 0.033 0.026 DBMET02045 0.036 0.021 DBMET02046 | ||
| 0.185 | 0.159 | 0.185 | Transcription factor STAT inhibitor | |||
| 0.035 | 0.01 | 0.062 | Prostaglandin EP2 agonist | 0.038 0.009 DBMET02045 0.062 0.004 DBMET02046 | DBMET02046 | |
| 0.047 | 0.022 | 0.047 | Alpha 1L adrenoreceptor agonist | |||
| 0.05 | 0.028 | 0.05 | Microtubule stabilization | 0.045 0.035 DBMET02045 0.045 0.035 DBMET02046 | ||
| 0.105 | 0.086 | 0.122 | Estrogen antagonist | 0.112 0.071 DBMET02045 0.122 0.052 DBMET02046 | DBMET02046 | |
| 0.103 | 0.083 | 0.105 | Interleukin 2 antagonist | 0.105 0.077 DBMET02045 | DBMET02045 | |
| 0.024 | 0.005 | 0.027 | Vitamin D receptor agonist | 0.027 0.004 DBMET02045 0.025 0.004 DBMET02046 | DBMET02045 | |
| 0.06 | 0.042 | 0.06 | Aromatase inhibitor | |||
| 0.108 | 0.091 | 0.159 | Alpha-N-acetylglucosaminidase inhibitor | 0.135 0.065 DBMET02045 0.159 0.05 DBMET02046 | DBMET02046 | |
| 0.04 | 0.024 | 0.046 | 5-Alpha-reductase inhibitor | 0.037 0.026 DBMET02045 0.046 0.02 DBMET02046 | DBMET02046 | |
| 0.039 | 0.025 | 0.039 | Vanilloid 3 antagonist | |||
| 0.039 | 0.028 | 0.039 | Histone deacetylase 9 inhibitor | |||
| 0.085 | 0.074 | 0.085 | Glutamate release inhibitor | |||
| 0.027 | 0.017 | 0.027 | Nicotinic acid receptor 2 antagonist | |||
| 0.069 | 0.059 | 0.092 | CDC25A inhibitor | 0.092 0.032 DBMET02045 0.088 0.036 DBMET02046 | DBMET02045 | |
| 0.038 | 0.029 | 0.048 | Membrane dipeptidase inhibitor | 0.048 0.017 DBMET02046 | DBMET02046 | |
| 0.03 | 0.023 | 0.059 | Prostaglandin agonist | 0.029 0.024 DBMET02045 0.059 0.008 DBMET02046 | DBMET02046 | |
| 0.07 | 0.065 | 0.07 | Vanilloid 4 agonist | |||
| 0.019 | 0.015 | 0.019 | Progesterone receptor B antagonist | |||
| 0.004 | 0.003 | 0.004 | Vitamin D-like | |||
| 0.039 | 0.039 | 0.04 | Liver X receptor agonist | 0.04 0.035 DBMET02046 | DBMET02046 | |
| 0.04 | 0.04 | 0.068 | Antimetabolite | 0.068 0.022 DBMET02046 | DBMET02046 | |
| 0.065 | 0.066 | 0.099 | Peroxisome proliferator-activated receptor gamma antagonist | 0.099 0.016 DBMET02046 | DBMET02046 | |
| 0.019 | 0.023 | 0.036 | Prostaglandin E2 agonist | 0.036 0.008 DBMET02046 | DBMET02046 | |
| 0.064 | 0.069 | 0.067 | Glycine receptor agonist | 0.067 0.061 DBMET02046 | DBMET02046 | |
| 0.009 | 0.016 | 0.034 | Prostaglandin EP4 agonist | 0.034 0.006 DBMET02046 | DBMET02046 | |
| 0.045 | 0.057 | 0.062 | Leukotriene B4 antagonist | 0.053 0.039 DBMET02045 0.062 0.026 DBMET02046 | DBMET02046 | |
| 0.03 | 0.042 | 0.034 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.034 0.032 DBMET02045 | DBMET02045 | |
| 0.051 | 0.063 | 0.054 | Leukotriene C antagonist | 0.054 0.046 DBMET02046 | DBMET02046 | |
| 0.138 | 0.151 | 0.199 | Insulin sensitizer | 0.199 0.074 DBMET02046 | DBMET02046 | |
| 0.08 | 0.094 | 0.159 | GABA C receptor agonist | 0.159 0.031 DBMET02046 | DBMET02046 | |
| 0.048 | 0.064 | 0.057 | Adenine nucleotide translocase inhibitor | 0.057 0.035 DBMET02046 | DBMET02046 | |
| 0.033 | 0.053 | 0.103 | Peroxisome proliferator-activated receptor alpha agonist | 0.045 0.036 DBMET02045 0.103 0.012 DBMET02046 | DBMET02046 | |
| 0.179 | 0.206 | 0.309 | Antithrombotic | 0.199 0.179 DBMET02045 0.309 0.082 DBMET02046 | DBMET02046 | |
| 0.17 | 0.199 | 0.185 | Tyrosine 3 hydroxylase inhibitor | 0.185 0.165 DBMET02046 | DBMET02046 | |
| 0.139 | 0.168 | 0.166 | Growth factor agonist | 0.166 0.109 DBMET02046 | DBMET02046 | |
| 0.142 | 0.173 | 0.25 | Spasmolytic | 0.25 0.091 DBMET02045 | DBMET02045 | |
| 0.035 | 0.07 | 0.05 | Glucose-6-phosphate isomerase inhibitor | 0.05 0.029 DBMET02046 | DBMET02046 | |
| 0.07 | 0.104 | 0.087 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.087 0.069 DBMET02046 | DBMET02046 | |
| 0.037 | 0.073 | 0.082 | Aconitate hydratase inhibitor | 0.082 0.013 DBMET02046 | DBMET02046 | |
| 0.072 | 0.109 | 0.107 | Expectorant | 0.107 0.061 DBMET02046 | DBMET02046 | |
| 0.017 | 0.068 | 0.045 | Fumarate hydratase inhibitor | 0.045 0.016 DBMET02046 | DBMET02046 | |
| 0.04 | 0.094 | 0.063 | Leukotriene antagonist | 0.063 0.047 DBMET02046 | DBMET02046 | |
| 0.042 | 0.104 | 0.064 | Porphobilinogen synthase inhibitor | 0.064 0.062 DBMET02046 | DBMET02046 | |
| 0.012 | 0.093 | 0.031 | Peroxisome proliferator-activated receptor delta agonist | 0.031 0.026 DBMET02046 | DBMET02046 | |
| 0.007 | 0.1 | 0.037 | Prostaglandin EP3 antagonist | 0.037 0.016 DBMET02046 | DBMET02046 | |
| 0.029 | 0.123 | 0.083 | Phosphofructokinase-1 inhibitor | 0.083 0.039 DBMET02046 | DBMET02046 | |
| 0.09 | 0.195 | 0.131 | Growth hormone agonist | 0.131 0.106 DBMET02046 | DBMET02046 | |
| 0.08 | 0.185 | 0.255 | Angiogenesis stimulant | 0.255 0.068 DBMET02045 0.146 0.125 DBMET02046 | DBMET02045 | |
| 0.041 | 0.147 | 0.054 | Lipocortins synthesis agonist | 0.054 0.052 DBMET02046 | DBMET02046 | |
| 0.013 | 0.18 | 0.103 | Prostaglandin EP2 antagonist | 0.103 0.018 DBMET02046 | DBMET02046 | |
| 0.037 | 0.264 | 0.094 | Uric acid excretion stimulant | 0.082 0.079 DBMET02045 0.094 0.059 DBMET02046 | DBMET02046 | |
| 0.027 | 0.262 | 0.065 | Histone deacetylase SIRT1 stimulant | 0.065 0.062 DBMET02045 | DBMET02045 | |
| 0.027 | 0.262 | 0.065 | Histone deacetylase stimulant | 0.065 0.062 DBMET02045 | DBMET02045 | |
| 0.056 | 0.381 | 0.126 | NOS3 expression enhancer | 0.126 0.103 DBMET02046 | DBMET02046 | |
| 0.025 | 0.389 | 0.083 | Aminoacyl-tRNA synthetase inhibitor | 0.083 0.071 DBMET02046 | DBMET02046 | |
| 0.086 | 0.543 | 0.168 | Peptidyltransferase inhibitor | 0.168 0.151 DBMET02045 | DBMET02045 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |